Da-Eon Lee1, Tae-Hwan Jung2, Yu-Na Jo1, Sung-Seob Yun3, Kyoung-Sik Han1,2. 1. Department of Food and Biotechnology, Sahmyook University, Seoul 01795, Korea. 2. Convergence Research Center, Sahmyook University, Seoul 01795, Korea. 3. R&D Department, Bioprofoods Co. Ltd., Seoul 01795, Korea.
Hypertension is defined as blood pressure (BP) chronically higher than 140/90 mmHg
(Chockalingam, 2008). It has been
identified as a risk factor for cardiovascular diseases (CVDs) and related
complications, including atherosclerosis and stroke (Danaei et al., 2013). The underlying mechanisms of hypertension involve
numerous pathways and factors, including the renin-angiotensin system (RAS),
oxidative stress, inflammation, and impaired nitric oxide (NO) generation (Jahandideh et al., 2016). In RAS,
angiotensin-converting enzyme (ACE) converts angiotensin (Ang) I into Ang II, which
increases BP. ACE inhibitors block this conversion and cause the blood vessels to
relax, decreasing the blood volume, whereby they exert a BP-lowering effect and
improve endothelial function (Wu et al.,
2017).Another mechanism affecting BP involves endothelial nitric oxide synthase (eNOS)
(Heiss et al., 2015). This enzyme is
vital for the maintenance of endothelial homeostasis. It generates NO, which
stimulates guanylate cyclase to form cyclic guanosine monophosphate. This cyclic
nucleotide causes proliferation of vascular smooth muscle cells and prevents
platelet adhesion and inflammation (Behrendt and
Ganz, 2002). A substantial amount of evidence indicates that NO has a
modulatory effect on BP, and impaired NO bioavailability is correlated with
endothelial dysfunction, promoting atherosclerosis in both hypertension and CVDs
(Endemann and Schiffrin, 2004; Hermann et al., 2006). Furthermore, NO has been
demonstrated to downregulate plasma Ang II level in spontaneously hypertensiverats
(SHRs), thereby inhibiting Ang II-dependent vasoconstriction (Rajapakse et al., 2016).Development of functional foods using food-derived proteins and peptides has become a
major research interest for the use of natural resources in the prevention and
management of hypertension due to the side-effects of the commonly used hypotensive
pharmaceuticals (Khanna et al., 2008; Viera, 2012). The ACE-inhibitory potentials of
various food-derived peptides have been extensively determined (FitzGerald et al., 2004; Gobbetti et al., 2004; Miguel
et al., 2005). Moreover, it has been appreciated that food-derived
peptides can be therapeutically used for the modulation of NO levels to reduce BP
(Aluko, 2015).Egg white is an inexpensive and rich source of high-quality proteins. Egg white
protein (EWP) hydrolysate (EWH) obtained with various proteases has been found to
exhibit several bioactivities, such as ACE inhibition, vasodilation, and antioxidant
activity, whereby it suppress CVDs (Davalos at al.,
2004; Grootaert et al., 2017;
Jahandideh et al., 2016; Miguel et al., 2007). Therefore, this study
aimed to prepare the EWH with hypoallergenic property using food-grade proteases and
to investigate the hypotensive effect of EWH in SHRs for the development of
functional foods as BP modulators.
Materials and Methods
Sample preparation
Egg white powder was purchased from SANOVO technology group (Odense, Denmark). To
prepare the EWH (EggNOpepTM), a mix of bromelain (0.5%, w/v) and
papain (1%, w/v) was added into the egg white solution (10%, w/v), and the
resulting mixture was incubated at 50°C for 60 min. Subsequently, the
mixture was heated at 95°C for 10 min to inactivate the enzymes and then
lyophilized. The degree of hydrolysis of the EWH was confirmed by SDS-PAGE
according to the method of Laemmli
(1970).
Measurement of allergenic properties
The allergenic properties of EWP and EWH were investigated using the method
described by Jung et al. (2017). A human
mast cell line (HMC-1 cells) was grown in Dulbecco's modified
Eagle's medium (Merck, Darmstadt, Germany) containing 10% fetal bovine
serum (Cellgro, USA) and 1% penicillin (Gibco, USA) at 37°C in a
humidified atmosphere with 5% CO2. The cells were cultured in a
24-well plate (105 cells/well) overnight, and then incubated for an
additional 24 h with 10 μg/mL of compound 48/80 (Merck) as a positive
control, 100 μg/mL of EWP or 100 μg/mL of EWH. Subsequently, the
tumor necrosis factor-α (TNF-α) and histamine levels in the
culture supernatants were quantified using the human TNF-α ELISA
Ready-SET-Go (eBioscience, San Diego, CA, USA) and histamine ELISA kits (IBL
International, Hamburg, Germany), respectively as per the manufacturers'
instructions.
Measurement of NO levels
The blood-brain barrier hCMEC/D3 cell line (MD Millipore, MA, USA) was cultured
with the EndoGRO LS complete culture media kit (Merck) as recommended by the
manufacturer. The cells were incubated in a 24-well plate at 37°C in a
humidified atmosphere with 5% CO2 and then treated with EWP or EWH at
1% for 24 h. Subsequently, the NO levels in the culture supernatants were
quantitated using the total NO and nitrate/nitrite parameter assay kit
(R&D Systems, Minneapolis, MN, USA). The plasma NO levels of SHRs were
determined with the same kit. Briefly, 100 μL of sample was reacted with
100 μL of the reaction diluent, and Griess reagents I and II following
the kit protocol. Absorbance was measured at 540 nm using a microplate reader
(Emax; Molecular Devices, San Jose, CA, USA).
Animal study
This study was approved by the Animal Ethics Committee of Sahmyook University
(SYU-IACUC-2018-008). Male SHRs that were 8 weeks old and weighed 264±21
g, were obtained from Charles River Laboratories Inc. (Japan). The SHRs were
housed in a room maintained at 22±2°C with a 12 h light/dark
cycle. All the SHRs had free access to water, and food was provided ad
libitum in powdered form. After acclimatization for 1 wk, the SHRs
were randomly divided into three groups (n=5), which were fed for 28 d either
the basal diet (AIN-93A) or one of the two test diets containing either EWP or
EWH at 1% (w/w).
Post-mortem procedures
At the end of the experiment, the SHRs were sacrificed by asphyxiation using
CO2 gas. The blood was collected by cardiac puncture, and a
portion was immediately transferred into a BD vacutainer blood collection tube
containing EDTA (Plymouth, UK). The blood plasma was isolated by centrifugation
at 10,000×g at 4°C for 20 min and then stored at
–80°C until further analysis.
Measurement of BP
BP was measured every third day during the experimental period (at 0, 3, 6, 9,
12, 15, 18, 21, 24, and 27 d) by non-invasive tail-cuff plethysmography. The
systolic BP (SBP) and diastolic BP (DBP) were measured using the BP analysis
system (NIBP-2000, Visitech Systems, Apex, NC, USA). All the measurements were
recorded by the same person in a quiet room to reduce stress-induced variations.
The final values were calculated from ten successive measurements.
Analysis of plasma Ang II levels
The plasma Ang II levels of the SHRs fed the test diets were measured with the
Ang II ELISA kit (LifeSpan BioSciences, Seattle, WA, USA) according to the
manufacturer's guidelines.
Statistical analysis
Results are expressed as means±SEM. Data were analyzed using ANOVA and
X2 test using the SAS software (GLM procedures, version 9.1, SAS
Institute, Cary, NC, USA). Means were compared using Duncan's multiple range
test. The two-tailed p-value less than 0.05 was considered significant.
Results and Discussion
Preparation and allergenic properties of EWH
EWP was effectively hydrolyzed by incubation with the combination of 0.5%
bromelain and 1% papain at 50°C for 60 min, as assessed by the reduced
levels of the major protein bands observed in SDS-PAGE (Fig. 1A). The HMC-1 cells were incubated with EWH or EWP to
investigate whether these samples elicited an allergic reaction. Toward this
end, the TNF-α and histamine levels in the culture supernatant were
measured. These compounds are known to be released by mast cells as an
inflammatory response to allergens. The ovalbumin in EWP is reported to result
in allergic response by inducing TNF-α and histamine release (Chen et al., 2019).
Fig. 1.
SDS-PAGE analysis of EWP and EWH (A), and measurement of TNF-α
(pg/mL) and histamine (ng/mL) levels in the culture supernatant of human
mast cells (HMC-1) treated with EWP or EWH (B, C).
Values are expressed as mean±SEM (n=5). a,b Means with
superscripts without a common letter differ, p<0.01. M, protein
molecular weight marker; C48/80, compound 48/80; EWP, egg white protein;
EWH, egg white protein hydrolysate.
SDS-PAGE analysis of EWP and EWH (A), and measurement of TNF-α
(pg/mL) and histamine (ng/mL) levels in the culture supernatant of human
mast cells (HMC-1) treated with EWP or EWH (B, C).
Values are expressed as mean±SEM (n=5). a,b Means with
superscripts without a common letter differ, p<0.01. M, protein
molecular weight marker; C48/80, compound 48/80; EWP, egg white protein;
EWH, egg white protein hydrolysate.Treatment of compound 48/80 (positive control) stimulated HMC-1 cells to release
both compounds, while EWH significantly (p<0.01) suppressed this
inflammatory response compared to the control. Moreover, the TNF-α and
histamine levels were significantly (p<0.01) lower in the culture treated
with EWH than in EWP-treated culture (Fig.
1B and 1C).Although EWP is considered one of the common food allergens, EWP-derived peptides
have been documented to have antioxidant and ACE inhibitory bioactivities (Duan et al., 2014; Jahandideh et al., 2014). Our results showed that the
enzymatic hydrolysis of EWP effectively reduced allergic response. The complex
peptide population produced by the hydrolysis of EWP may have contributed to the
hypotensive effect observed in this study.
Measurement of BP in SHRs
The SHR strain is a suitable rodent model for hypertension. These rats show
impaired vascular function and higher levels of Ang II, oxidative stress, and
inflammation compared to wild type rats (Ikarashi et al., 2018). The SBP and DBP baselines in all the
experimental groups were approximately 140 mmHg and 80 mmHg, respectively,
indicating the presence of hypertension, and these values are similar to those
in humans with essential hypertension (Okamoto
and Aoki, 1963).To evaluate whether EWH exerted a hypotensive effect, SBPs and DBPs of the SHRs
fed the test diets were measured every 3 d for 4 wk. The SBP of EWH group was
significantly lower than those of the other groups after 6 d of the treatment
except for 15 d (Fig. 2A). At the end of
the study, the SBP of EWH group was similar (146±3.27 mmHg) to the
baseline value at the beginning, whereas the SBPs of the control and EWP groups
were 172.9±6.22 mmHg and 186.0±3.26 mmHg, respectively. Moreover,
the DBP of EWH group was maintained at a constant rate of 62.9±7.95 mmHg
during the experiment period and was significantly lower than the DBPs of the
other groups except for 12 and 21 d (Fig.
2B).
Fig. 2.
Comparison of the blood pressure of the spontaneously hypertensive
rats fed the test diets for 28 d.
Values are expressed as mean±SEM (n=5). (A) Systolic blood
pressure, (B) diastolic blood pressure. * p<0.05,
** p<0.01, *** p<0.001 vs. the
control group. Control, untreated; EWP, egg white protein; EWH, egg
white protein hydrolysate.
Comparison of the blood pressure of the spontaneously hypertensive
rats fed the test diets for 28 d.
Values are expressed as mean±SEM (n=5). (A) Systolic blood
pressure, (B) diastolic blood pressure. * p<0.05,
** p<0.01, *** p<0.001 vs. the
control group. Control, untreated; EWP, egg white protein; EWH, egg
white protein hydrolysate.A number of studies have investigated complementary approaches that are based on
dietary resources to attenuate hypertension. Especially, the enzymatic
hydrolysates of various food proteins, such as those of rice bran, egg white,
and milk have been proven to be rich sources of bioactive peptides that exert
beneficial effects on hypertension, lipid profile, inflammation, and oxidative
stress in vitro and in vivo (Boonla et al., 2015; Davalos et al., 2004; Ganguly et al., 2019; Manso et al.,
2008; Miguel et al., 2005;
Phelan and Kerins, 2011).
Measurement of NO and Ang II levels
The blood-brain barrier hCMEC/D3 cells were incubated with EWH or EWP. The NO
level in the culture supernatant increased more than 2-fold upon EWH treatment
as compared to that in the control group (Fig.
3A). Similarly, the NO levels in the blood of the SHRs fed the EWH
diet were significantly (p<0.05) higher than in the control group (Fig. 3B).
Fig. 3.
Nitric oxide levels in the culture supernatant of hCMEC/D3 cells (A)
and blood plasma of the spontaneously hypertensive rats fed the test
diets for 28 d (B).
Values are expressed as mean±SEM (n=5). a,b Means with
superscripts without a common letter differ, p<0.05. Control,
untreated; EWP, egg white protein; EWH, egg white protein
hydrolysate.
Nitric oxide levels in the culture supernatant of hCMEC/D3 cells (A)
and blood plasma of the spontaneously hypertensive rats fed the test
diets for 28 d (B).
Values are expressed as mean±SEM (n=5). a,b Means with
superscripts without a common letter differ, p<0.05. Control,
untreated; EWP, egg white protein; EWH, egg white protein
hydrolysate.In general, BP is modulated through various mechanisms, such as adjustment of ACE
activity, vascular function, and oxidative status. Upregulation of the NO level
is another mechanism underlying vascular relaxation. It has been suggested that
NO in the brain regulates BP by affecting sympathetic nerve activity (Rajapakse et al., 2016). NO in specific
regions of the central nervous system has been shown to play a significant role
in cardiovascular regulation. Among these regions, the rostral ventrolateral
medulla is responsible for basal and reflex-action control of sympathetic nerve
activity and has been shown to be related to CVDs, such as hypertension (Kishi et al., 2001). Our results suggest
that EWH could contribute to these vasodilatory mechanisms.Additionally, the plasma Ang II levels were assessed in the SHRs fed the test
diets. As shown in Fig. 4, orally
administered EWH significantly (p<0.01) reduced the plasma Ang II level
compared with that in the control group. However, the effect of EWH did not
significantly differ than that of EWP.
Fig. 4.
Angiotensin II levels in the plasma of the spontaneously hypertensive
rats fed the test diets for 28 d.
Values are expressed as mean±SEM (n=5). a,b Means with
superscripts without a common letter differ, p<0.01. Control,
untreated; EWP, egg white protein; EWH, egg white protein
hydrolysate.
Angiotensin II levels in the plasma of the spontaneously hypertensive
rats fed the test diets for 28 d.
Values are expressed as mean±SEM (n=5). a,b Means with
superscripts without a common letter differ, p<0.01. Control,
untreated; EWP, egg white protein; EWH, egg white protein
hydrolysate.We also observed that EWH had an inhibitory effect on ACE in
vitro (data not shown), and thus it is possible that EWH
downregulates circulating Ang II level in SHRs. ACE inhibitors are essentially
used as a therapeutic approach in the regulation of high BP. Downregulation of
Ang II suppresses the causative mechanisms of high BP through the RAS pathways
(Bader and Ganten, 2008; Hermann et al., 2006). Aluko (2015) has reported that enzymatic
hydrolysis of inactive food proteins releases bioactive peptides that enhance
the eNOS pathway, resulting in upregulation of NO within vascular walls, and
interrupt the interaction between Ang II and its receptors.In conclusion, bioactive peptides obtained by hydrolysis of food-proteins such as
EWP can prevent and manage hypertension beyond their basic nutritional values.
The results of this study confirm the hypotensive and hypoallergenic properties
of EWH, which can be a valuable resource for functional food development.
However, further research is required to identify the specific peptides
associated with the modulation of BP.